Commodore Capital as of June 30, 2025
Portfolio Holdings for Commodore Capital
Commodore Capital holds 33 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 13.1 | $185M | 3.5M | 52.60 | |
| Nuvalent Inc-a (NUVL) | 7.4 | $105M | 1.4M | 76.30 | |
| Xenon Pharmaceuticals (XENE) | 6.7 | $95M | 3.0M | 31.30 | |
| Enliven Therapeutics (ELVN) | 6.6 | $94M | 4.7M | 20.06 | |
| Agios Pharmaceuticals (AGIO) | 5.5 | $77M | 2.3M | 33.26 | |
| Celldex Therapeutics Com New (CLDX) | 5.0 | $70M | 3.5M | 20.35 | |
| Alkermes SHS (ALKS) | 4.9 | $70M | 2.5M | 28.61 | |
| Miragen Therapeutics (VRDN) | 4.8 | $68M | 4.9M | 13.98 | |
| Protagonist Therapeutics (PTGX) | 4.2 | $59M | 1.1M | 55.27 | |
| Cidara Therapeutics Com New (CDTX) | 4.0 | $57M | 1.2M | 48.71 | |
| Scholar Rock Hldg Corp (SRRK) | 3.6 | $51M | 1.5M | 35.42 | |
| Soleno Therapeutics (SLNO) | 3.6 | $51M | 610k | 83.78 | |
| Relay Therapeutics (RLAY) | 3.3 | $46M | 13M | 3.46 | |
| Nurix Therapeutics (NRIX) | 3.2 | $45M | 3.9M | 11.39 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 3.1 | $43M | 3.3M | 13.14 | |
| Pharvaris N V (PHVS) | 2.4 | $34M | 1.9M | 17.60 | |
| Kymera Therapeutics (KYMR) | 2.3 | $33M | 750k | 43.64 | |
| Mind Medicine Mindmed Com New (MNMD) | 2.3 | $33M | 5.0M | 6.49 | |
| Spyre Therapeutics Com New (SYRE) | 2.1 | $30M | 2.0M | 14.97 | |
| Tyra Biosciences (TYRA) | 2.1 | $30M | 3.1M | 9.57 | |
| Vera Therapeutics Cl A (VERA) | 1.3 | $19M | 800k | 23.56 | |
| Cytomx Therapeutics (CTMX) | 1.2 | $18M | 7.7M | 2.27 | |
| Cogent Biosciences (COGT) | 1.2 | $17M | 2.3M | 7.18 | |
| Oruka Therapeutics (ORKA) | 1.1 | $16M | 1.4M | 11.21 | |
| Bright Minds Biosciences Com New (DRUG) | 0.9 | $13M | 500k | 26.11 | |
| Apogee Therapeutics (APGE) | 0.9 | $13M | 290k | 43.43 | |
| Inhibikase Therapeutics Com New (IKT) | 0.7 | $11M | 5.4M | 1.95 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.6 | $8.0M | 750k | 10.62 | |
| Tango Therapeutics (TNGX) | 0.5 | $7.7M | 1.5M | 5.12 | |
| Crescent Biopharma (CBIO) | 0.5 | $7.3M | 454k | 16.14 | |
| Neurogene (NGNE) | 0.5 | $6.4M | 428k | 14.95 | |
| Vistagen Therapeutics Ord (VTGN) | 0.2 | $3.2M | 1.6M | 2.00 | |
| Avalo Therapeutics Com New (AVTX) | 0.2 | $2.4M | 483k | 4.99 |
